CION Ameerpet
A craniopharyngioma is a benign (non-cancerous) brain tumour, but its location near the pituitary and optic nerves means it needs careful, expert care. CION's tumour board plans treatment that protects your vision and hormones.
A craniopharyngioma is a rare, benign (non-cancerous) brain tumour. It is classed as WHO Grade 1, the lowest grade, and it does not spread to other organs. It grows from leftover cells near the pituitary gland — the small hormone-control gland at the base of the brain — in an area called the sellar and suprasellar region.
Here is the important part: "benign" does not mean harmless. A craniopharyngioma sits in a very crowded, delicate part of the brain — right next to the optic nerves (which carry vision), the pituitary gland (which controls your hormones), and the hypothalamus (which controls thirst, temperature and appetite). Even a slow-growing tumour here can press on these structures and cause real, lasting problems if it is not treated with care. That is why expert, coordinated treatment matters — even for a tumour that is not cancer.
Craniopharyngiomas affect both children and adults. There is one peak in childhood and a second peak in adults aged about 50 to 75. This page focuses on craniopharyngioma in adults. For families of younger patients, our dedicated page on craniopharyngioma in children explains how care differs for paediatric patients.
A craniopharyngioma sits so close to the pituitary gland that the gland and the tumour are often hard to tell apart. Because of this, the European Association of Neuro-Oncology (EANO) recommends that vision (ophthalmology) and hormone (endocrine) assessments are done before treatment begins, and that treatment is planned to protect these functions — not just to remove the tumour. The goal of modern care is long-term tumour control with the fewest possible side effects.
Because both tumours grow in the same small area near the pituitary gland, they can look similar on a first scan and cause overlapping symptoms. But they are different tumours, and they are treated differently.
A benign tumour that grows from leftover developmental cells above and around the pituitary gland. It is often partly solid and partly fluid-filled (cystic), and it commonly presses on the optic nerves causing vision loss. It is managed with surgery, focused radiation, and lifelong hormone support. It is not treated with hormone-blocking tablets.
A tumour of the pituitary gland itself — usually benign. Some types overproduce a hormone (like prolactin), and a few can be controlled with medicine alone. The treatment menu is different. If your scan or report mentions the pituitary, our page on pituitary adenoma explains how it is diagnosed and managed.
Getting the diagnosis exactly right is the first job of CION's tumour board. Send us your MRI report for a free review, or explore the full brain cancer & tumour hub.
In adults, the symptoms of a craniopharyngioma usually come on slowly, over months, because the tumour grows gently and presses on nearby structures bit by bit. This is one reason the diagnosis is often delayed — the early signs are easy to put down to stress, ageing, or a thyroid problem. The symptoms fall into three main groups:
When to get checked: a craniopharyngioma is a rare cause of these symptoms — most thirst, tiredness or blurred vision has an everyday explanation. But a new, persistent loss of side vision, especially together with hormonal symptoms, should always be assessed with a brain MRI and a hormone review. Talk to a CION specialist if this sounds like you.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Whether you have just been diagnosed or want a second opinion before surgery, CION's tumour board will explain your options — and how each one protects your vision and hormones.
Diagnosing a craniopharyngioma well means looking at three things together: the tumour itself, your vision, and your hormones. At CION, all three assessments are arranged before any treatment decision is made.
MRI is the main test. A contrast MRI shows the tumour's exact position, its size, and whether it is solid, fluid-filled (cystic), or a mix of both. It also shows how close the tumour is to the optic nerves and pituitary gland — which is essential for planning safe treatment. Specks of calcium within the tumour, often seen on imaging, are a classic feature of craniopharyngioma. Read more about how to interpret a contrast MRI of a brain tumour.
Because the tumour sits on the pituitary gland, blood tests check the levels of thyroid, adrenal (cortisol), growth and reproductive hormones, plus water-balance status. Many adults already have one or more hormone deficiencies at diagnosis, and identifying these early means they can be safely replaced before treatment, which lowers the risks of surgery and radiation.
A formal eye test, including a visual field test that maps your side vision, records exactly how much the tumour is affecting your sight. This becomes the baseline against which improvement after treatment is measured.
There is no single "best" treatment for every craniopharyngioma. The right plan depends on the tumour's size, whether it is solid or cystic, how close it is to the optic nerves, and your current vision and hormone status. CION's multidisciplinary tumour board weighs all of this before recommending a path. The modern aim is long-term tumour control with the least possible damage to vision and hormones — which often means a planned combination rather than one aggressive step.
Surgery aims to remove as much of the tumour as can be done safely and to relieve pressure on the optic nerves. Two main approaches are used: the transsphenoidal route (through the nose and sinuses, with no external incision) for suitable tumours, and an open (transcranial) approach for larger or more complex tumours. At CION, all neurosurgery for craniopharyngioma is coordinated with accredited neurosurgical partners — CION's neuro-oncology team plans your overall care, while the surgery itself is performed by partnered neurosurgical specialists. Modern practice often favours a planned partial removal followed by focused radiation, because attempting complete removal near the optic nerves and hypothalamus can cause more harm than good.
Radiation is used to control any tumour left after surgery, or as the main treatment when surgery is too risky. CION delivers radiation therapy in-house using precision techniques — IMRT and IGRT, and stereotactic radiosurgery for small, well-defined targets, provided as part of coordinated radiosurgery/specialist care. Focused radiation lets us treat the tumour while sparing the nearby optic nerves and healthy brain as much as possible. You can read more about brain tumour treatment in Hyderabad and how radiation fits into the wider plan.
For mainly fluid-filled (cystic) craniopharyngiomas, draining the cyst can quickly relieve pressure and improve vision. Throughout and after treatment, an endocrinologist manages hormone replacement so your thyroid, cortisol, water balance and other hormones stay properly supported — this is delivered directly by CION's care team.
Most adults treated for a craniopharyngioma go on to lead full, active lives. Because this is a benign tumour, the focus of long-term care is on two things: keeping the tumour controlled, and keeping your hormones and vision well managed.
Because a craniopharyngioma can recur even years after successful treatment, the National Comprehensive Cancer Network (NCCN) and EANO both recommend long-term MRI surveillance rather than a fixed end-date for follow-up. A recurrence is not a sign that the first treatment failed — it is a known feature of this tumour, and focused radiation or repeat surgery can usually bring it back under control.
Craniopharyngioma decisions are nuanced and they affect you for life, so a second opinion is genuinely worthwhile. Consider one if:
CION offers a free written second opinion, with every case reviewed by a multidisciplinary tumour board — see our brain tumour second opinion service. You can also call us directly on 18002028726 to talk through your scan and report.
Get a free written second opinion from CION's tumour board — especially valuable before craniopharyngioma surgery, or if radiation options and a hormone assessment have not been discussed.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.No. A craniopharyngioma is a benign (non-cancerous) brain tumour — it is graded WHO Grade 1 and does not spread to other parts of the body. However, "benign" does not mean harmless. Because it sits near the pituitary gland, optic nerves and hypothalamus, even a slow-growing craniopharyngioma can press on these structures and cause vision loss, hormone problems and other symptoms. That is why it still needs careful, expert treatment. The goal of care is to relieve pressure, protect vision and hormones, and control the tumour long-term — not to treat it as a cancer with chemotherapy.
In adults, the most common early symptoms come from pressure on nearby structures. These include gradual vision changes (loss of side vision, blurred vision), headaches, and hormone-related symptoms such as fatigue, low libido, irregular periods, increased thirst and frequent urination (from diabetes insipidus). Many of these symptoms are subtle and develop slowly, so they are often mistaken for stress, ageing or thyroid problems for months. A craniopharyngioma is a rare cause — but any new, persistent vision change combined with hormonal symptoms deserves a brain MRI and a hormone (endocrine) review.
Treatment is tailored to the tumour's size, location and your hormone and vision status. The two main approaches are surgery (to remove or reduce the tumour) and radiation therapy (often stereotactic radiosurgery or fractionated radiation for residual or recurrent tumour). At CION, neurosurgery — including transsphenoidal (through-the-nose) or open approaches — is coordinated with accredited neurosurgical partners. CION directly delivers the radiation therapy (IMRT/IGRT), imaging, hormone and supportive care, and the multidisciplinary tumour board review that decides the safest plan. Many centres now favour planned partial removal followed by focused radiation to protect vision and hormone function.
Often, yes. The craniopharyngioma and its treatment can damage the pituitary gland, which controls thyroid, adrenal, growth and reproductive hormones, plus water balance. Many adults need hormone replacement — for example thyroid hormone, cortisol (steroid), and sometimes desmopressin for diabetes insipidus. This is managed by an endocrinologist as part of your CION care team. With the right replacement, most people lead full, active lives. Regular hormone monitoring is a normal part of follow-up, and your team will adjust doses over time as needed.
Yes — craniopharyngiomas can recur, especially if the whole tumour could not be safely removed. This is why long-term MRI surveillance is essential, even after successful treatment. Recurrence is more likely in the first few years but can happen later, so follow-up scans continue for many years. If the tumour does regrow, options include further focused radiation, repeat surgery (coordinated with neurosurgical partners), or drainage of any fluid-filled (cystic) part. A recurrence is not a failure of treatment — it is a known feature of this tumour, and there are effective ways to manage it.
A second opinion is especially valuable for craniopharyngioma because the treatment decisions are nuanced and lifelong. It is worth seeking one if: aggressive total removal is being recommended without discussing the risk to vision and hormones; radiation therapy options (such as stereotactic radiosurgery) have not been explained; or an endocrine and ophthalmology assessment has not been arranged before treatment. CION offers a free written second opinion through our brain tumour second opinion service, with every case reviewed by a multidisciplinary tumour board.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.